|
|
Baxter International Inc (BAX) |
|
|
|
| |
Baxter International Inc Net Income per Employee
BAX's Quarterly Results, Trends, Rankings, Statistics
Baxter International Inc 's Income per employee fell in the second quarter 2024 on a trailing twelve month basis to $ 60,610, but the productivity of Baxter International Inc 's 41,000 employees remained above the company average. The Healthcare sector has seen employees of 13 other companies achieving higher income per employee. While income per employee total ranking has improved so far to 864, from total ranking in previous quarter at 982.
What is Income per Employee Ratio?
|
Select the Comparisons :
|
|
Select the Ratio:
|
|
| BAX Net Income per Employee |
(Jun 30 2024)
II. Quarter |
(Mar 31 2024)
I. Quarter |
(Dec 31 2023)
IV. Quarter |
(Sep 30 2023)
III. Quarter |
(Jun 30 2023)
II. Quarter |
| Y / Y Net Income Change |
- |
-13.33 % |
32.97 % |
- |
- |
| Net Income per Employee (TTM) $ |
60,610 |
64,805 |
64,951 |
63,463 |
-69,341 |
| BAX's Total
Ranking |
# 864 |
# 982 |
# 870 |
# 961 |
# 2210 |
| Seq. Net Income Change |
- |
-84.15 % |
-90.2 % |
- |
- |
| Net Income per Employee Statistics |
| High |
Average |
Low |
| $ 82,750 |
$ 26,752 |
$ -47,383 |
| (Dec 31 2016) |
|
(Jun 30 2023) |
News about Baxter International Inc |
|
BOSTON ?? In a significant move to enhance respiratory care, Baxter International Inc. (NYSE: BAX), a prominent player in medical technology, has launched its next-generation airway clearance system, The Vest Advanced Pulmonary Experience (APX) System. This unveiling took place during the much-anticipated North American Cystic Fibrosis Conference, where healthcare professionals and stakeholders gathered to explore innovations in treatments for chronic respiratory conditions.The Vest APX System is designed to support daily therapy for both adults and children suffering from chronic lung ailments, including cystic fibrosis and other disorders characterized by the retention of secretions. Building on the reliability of its predecessor, the new system integrates the trusted airflow technology that Baxter is known for, while also prioritizing user comfort. Enhanced features aim to provide a more effective and pleasant experience for patients, who depend on these therapies to maintain their health and improve their quality of life.
|
| Companies with similar Income per Employee for 12 month ending Jun 30 2024, within Healthcare Sector | Income per Employee | Income 12 month ending Jun 30 2024 | Number of Employees Jun 30 2024 | | Mimedx Group Inc | 103,138.55 | $ 92.309 Million | 895 | | Resmed Inc | 102,299.70 | $ 1,020.951 Million | 9,980 | | Castle Biosciences Inc | 101,768.29 | $ 16.690 Million | 164 | | Organon and Co | 100,000.00 | $ 1,000.000 Million | 10,000 | | Kaya Holdings Inc | 92,190.82 | $ 1.567 Million | 17 | | Iradimed Corporation | 91,423.89 | $ 18.285 Million | 200 | | Alpha Pro Tech Ltd | 89,166.67 | $ 10.700 Million | 120 | | Adma Biologics Inc | 86,754.42 | $ 34.789 Million | 401 | | American Shared Hospital Services | 81,862.75 | $ 4.175 Million | 51 | | Idexx Laboratories Inc | 76,875.36 | $ 845.629 Million | 11,000 | | Biomarin Pharmaceutical Inc | 75,445.16 | $ 256.589 Million | 3,401 | | Bio techne Corp | 75,379.13 | $ 173.372 Million | 2,300 | | Edwards Lifesciences Corporation | 74,212.12 | $ 1,469.400 Million | 19,800 | | Dexcom Inc | 69,468.75 | $ 666.900 Million | 9,600 | | Ufp Technologies Inc | 68,624.65 | $ 49.547 Million | 722 | | Revance Therapeutics Inc | 67,764.04 | $ 36.186 Million | 534 | | Stryker Corp | 66,307.69 | $ 3,448.000 Million | 52,000 | | Agilent Technologies inc | 64,972.38 | $ 1,176.000 Million | 18,100 | | Electromed Inc | 61,309.52 | $ 5.150 Million | 84 | | Mallinckrodt Plc | 61,071.43 | $ 171.000 Million | 2,800 | | Baxter International Inc | 60,609.76 | $ 2,485.000 Million | 41,000 | | Medpace Holdings Inc | 57,591.53 | $ 339.790 Million | 5,900 | | Gilead Sciences Inc | 57,388.89 | $ 1,033.000 Million | 18,000 | | 55,540.54 | $ 2.055 Million | 37 | | Msa Safety Inc | 53,340.98 | $ 272.039 Million | 5,100 | | West Pharmaceutical Services Inc | 49,518.87 | $ 524.900 Million | 10,600 | | Mettler Toledo International Inc | 49,109.25 | $ 785.748 Million | 16,000 | | Abbott Laboratories | 48,745.61 | $ 5,557.000 Million | 114,000 | | Revvity Inc | 48,669.22 | $ 559.696 Million | 11,500 | | Hims and Hers Health Inc | 45,484.92 | $ 18.103 Million | 398 |
Date modified: 2024-08-07T19:52:45+00:00
|
